CRISPRMED26 Hybrid Programme PDF (2026-04-10) The 3rd CRISPR Medicine Conference including the satellite meetings and the workshops, will take place at CPH Conference Center , located in Vesterbro district of the beautiful city of Copenhagen. Please check the location details here.
Chairpersons: Ulrich Storz, Patent Attorney, Co-founder and Senior Partner, Michalski Hüttermann & Partner, Germany. Franziska Bächler, Postdoctoral Researcher and Lecturer, Scientific Manager Center for Life Sciences Law, University of Basel, Switzerland. See updated programme.
Chairpersons: Pia Johansson (Lund University) and Rob Wolthuis (Amsterdam UMC) See updated programme. With the rapid expansion of CRISPR technology, dedicated CRISPR Centers and Facilities are emerging worldwide as hubs for innovation, infrastructure support, and education. The CRISPR Medicine conference provides an ideal platform to bring these centers together for the first time, to exchange experience and strengthen collaboration across Europe. This inaugural CRISPR Screening and Editing Facilities Forum will feature a mix of presentations and discussions focused on advancing technical and organizational aspects of CRISPR infrastructure. Topics include improving HDR efficiencies, developing and sharing screening methodologies, and managing facility operations. The forum will conclude with a panel discussion on practical challenges and opportunities for long-term collaboration among CRISPR Centers. By fostering dialogue between facility leaders and method developers, this meeting aims to lay the basis for a sustainable network of CRISPR Screening and Editing Facilities.
Chairpersons: Attila Sebe (PEI) and Lotte Dahl Nissen (DKMA) See updated programme. This satellite meeting is intended for developers of CRISPR-based medicinal products across academia, small and medium-sized enterprises (SMEs), and the pharmaceutical industry. The satellite meeting will be structured in three parts. The first part will provide an overview of the applicable regulatory framework and requirements in the EU. The presentations will focus on the quality, non-clinical, and clinical requirements necessary for clinical trial applications and marketing authorizations. The second part will feature a panel discussion where questions from the audience will be discussed. In the last part a “Meet the Expert” session will offer participants the opportunity to engage directly with regulatory specialists and presenters to discuss specific questions and challenges.
Selected speakers and virtual poster session
Official launch of EGMEDC 6:00 - Welcome 6:05-6:15 - Opening Address - Stine Bosse (MEP, EU Parliament) 6:15-6:25 - Søren Jarl Christensen, “August Foundation”, Denmark 6:25-6:35 - Liselotte Wesley Andersen, Chair person in Rare Disease , Denmark 6:35-7:00 - EGMEDC partners on the stage 7:00-9:00 reception with canapés and wine